Research Article

Plasma Total Cysteine and Cardiovascular Risk Burden: Action and Interaction

Table 3

Current medications in risk factor groups.

Total ( 𝑛 = 2 2 3 )Group 1 ( 𝑛 = 9 5 )Group 2 ( 𝑛 = 8 0 )Group 3 ( 𝑛 = 4 8 )

ACE inhibitors43 (19%)3 (3%)20 (25%)20 (42%)
Angiotensin II receptor antagonists18 (8%)4 (4%)6 (7%)8 (17%)
beta-blockers27 (12%)2 (2%)14 (17%)11 (23%)
Diuretics11 (5%)3 (3%)3 (4%)5 (10%)
Calcium-channel blockers36 (16%)3 (3%)19 (24%)14 (29%)
Antiplatelet agents28 (12%)6 (6%)13 (16%)9 (19%)
Statins33 (15%)3 (3%)12 (15%)18 (38%)
Antidiabetic agents42 (19%)7 (7%)16 (20%)19 (40%)
Number of drugs*1 [0; 2]0 [0; 1]1 [0; 2]2 [1; 3]

Data are expressed as number of patients (percentage).
*Number of drugs: sum of all drug classes reported above in the table, presented as median and interquartile range [I; III].
ACE: angiotensin converting enzyme.